PROSTACYCLINE, IHRE ANALOGE ODER PROSTAGLANDINE UND THROMBOXANANTAGONISTEN ZUR BEHANDLUNG VON THROMBOTISCHEN UND THROMBOEMBOLISCHEN KRANKHEITSBILDERN.

摘要

(A) The use of (1) prostacyclin (analogue) or a prostaglandin and (2) a thromboxane receptive antagonist either simultaneously but separately or at different times in the treatment of thrombotic and thromboembolic disease states is new. (B) Also new are combination prods. for use in thrombotic and thromboembolic disease states contg. (1) prostacyclin(analogue) or a prostaglandin and (2) a thromboxane receptor antagonist.